Naeve Gregory S. 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Aug 23, 2019
Insider Transaction Report
Form 4
Naeve Gregory S.
Sr. VP, Chief Business Officer
Transactions
- Tax Payment
Common Stock
2019-08-21$0.95/sh−1,597$1,513→ 13,746 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on August 21, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on August 21, 2017 for 15,000 shares, of which 3,750 vested on August 21, 2019. The RSUs vest in four equal annual installments beginning August 21, 2018.
- [F2]Includes 902 shares acquired by the reporting person under the Issuer's 2014 Employee Stock Purchase Plan on June 10, 2019.